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Abstract
Background: Osteoarthritis (OA) is characterized by the formation and deposition of calcium-containing crystals in
joint tissues, but the underlying mechanisms are poorly understood. The gasotransmitter hydrogen sulfide (H2S) has
been implicated in mineralization but has never been studied in OA. Here, we investigated the role of the H2S-
producing enzyme 3-mercaptopyruvate sulfurtransferase (3-MST) in cartilage calcification and OA development.
Methods: 3-MST expression was analyzed in cartilage from patients with different OA degrees, and in cartilage
stimulated with hydroxyapatite (HA) crystals. The modulation of 3-MST expression in vivo was studied in the
meniscectomy (MNX) model of murine OA, by comparing sham-operated to MNX knee cartilage. The role of 3-MST
was investigated by quantifying joint calcification and cartilage degradation in WT and 3-MST−/− meniscectomized
knees. Chondrocyte mineralization in vitro was measured in WT and 3-MST−/− cells. Finally, the effect of oxidative stress
on 3-MST expression and chondrocyte mineralization was investigated.
Results: 3-MST expression in human cartilage negatively correlated with calcification and OA severity, and diminished
upon HA stimulation. In accordance, cartilage from menisectomized OA knees revealed decreased 3-MST if compared
to sham-operated healthy knees. Moreover, 3-MST−/− mice showed exacerbated joint calcification and OA severity if
compared to WT mice. In vitro, genetic or pharmacologic inhibition of 3-MST in chondrocytes resulted in enhanced
mineralization and IL-6 secretion. Finally, oxidative stress decreased 3-MST expression and increased chondrocyte
mineralization, maybe via induction of pro-mineralizing genes.
Conclusion: 3-MST-generated H2S protects against joint calcification and experimental OA. Enhancing H2S production
in chondrocytes may represent a potential disease modifier to treat OA.
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Background
Osteoarthritis (OA) is the most common joint disease
affecting millions of people [1]. It is characterized by
cartilage degradation, subchondral bone sclerosis and
synovitis [2]. In addition, calcium-containing crystals
within joint structures are another prominent features
of OA, and they participate in its initiation and pro-
gression. These crystals were found in 50% up to
100% of synovial fluid [3] and cartilage [4] from OA
patients undergoing joint replacement. Two families
of calcium-containing crystals were identified in OA:
basic calcium phosphate (BCP) (e.g., hydroxyapatite
(HA)), and calcium pyrophosphate dihydrate (CPPD)
[5]. In vitro, BCP crystals induced catabolic and in-
flammatory responses [6, 7]. When injected into mice
knees, they caused mild synovitis but severe cartilage
damage, resembling human OA features [8]. In our
recent study, we observed BCP calcific deposits in
joints following meniscectomy. Moreover, we found
reciprocal crosstalk between BCP and IL-6 production
[9], and a positive correlation between these two en-
tities and the severity of cartilage degradation. Thus,
we hypothesize that inhibiting crystal formation and
deposition in the joint could be of therapeutic value
for OA treatment.
Hydrogen sulfide (H2S) is an endogenous gasotrans-
mitter in our body, together with nitric oxide (NO) and
carbon monoxide (CO) [10]. In mammalian tissues,
H2S is generated by three different enzymes: cystathio-
nine beta-synthase (CBS), cystathionine gamma-lyase
(CSE), and 3-mercaptopyruvate sulfurtransferase (3-
MST). These enzymes use cysteine as a substrate to
produce H2S [11, 12], and their expression is tissue-
specific. H2S showed biological effects [13] that can be
of relevance in OA, such as reduced pro-inflammatory
responses [14], reduced mineralization [15–18], im-
proved anabolic/catabolic balance [19, 20], and de-
creased oxidative stress (reactive oxygen species (ROS)
production) [21, 22]. H2S signaling occurs in part
through post-translational modification (namely, S-
sulfhydration) of specific cysteine residues in target
proteins with the potential to alter their function [23].
In addition, H2S oxidation leads to sulfite (SO3
2−), thio-
sulfate (S2O3
2−) [24], and sulfate (SO4
2−) generation in
the mitochondria [12], which could themselves mediate
H2S effects.
Current therapeutic approaches for OA are either symp-
tomatic or surgical. Therefore, there is a medical need for in-
terventions that target the pathological processes of OA. We
hypothesized that H2S can prevent calcium-containing crys-
tals deposition in the joint, and subsequently OA progres-
sion. In particular, we demonstrated that activation of the 3-
MST/H2S axis improved outcomes in both human and ex-
perimental OA.
Methods
Mice and experimental osteoarthritis
3-MST KO (n = 8) [25] and WT female mice (n = 8), 8-
weeks old, on a C57BL/6 background, were subjected to
medial meniscectomy (MNX) of the right knee, while
the contralateral knee was sham-operated as control
[26]. Two months after, mice were sacrificed, blood col-
lected, and serum obtained by 15 min centrifugation at
15000×g, and knees fixed in 10% formalin.
MicroCT-scan
MicroCT-scans analysis was performed using a SkyScan
1076® X-ray μCT scanning system (SkyScan, Belgium)
and the following parameters: 18 μm resolution, 60 kV,
167 μA, 0.4° rotation step over 360°, 0.5 mm Aluminum
filter, 1180 ms exposure time. Ex vivo samples acquisi-
tion was made using formol fixed knees. Images were re-
constructed using NRecon Version 1.6.6.0 (Skyscan,
Belgium) considering the following parameters: gray-
values = 0.0000–0.105867, ring artifact reduction = 3,
beam hardening correction = 40% [27]. Newly formed
calcific deposits at the site of the removed medial menis-
cus were considered as Volumes-Of-Interest (VOI) for
the quantitative analysis of new formation volume
(mm3) and new formation crystal content (μg) by CTA-
nalyzer V.1.10.
Mouse knee histology
Knees were decalcified in EDTA for 20 days and embed-
ded in paraffin. Sagittal sections (5 μm thick, 3 sections/
mouse, spaced 70 μM apart) of the medial compartment
were stained with Safranin-O and counterstained with
fast green/iron hematoxylin. Blinded OARSI score (0–24
score) [28] for cartilage damage and Safranin-O loss was
assessed by two independent observers.
Thiosulfate measurement
Serum was delipidized with dichloromethane and centri-
fuged. The supernatant was derivatized with monobro-
mobimane, acetonitrile, and HEPES/EDTA buffer (pH 8)
for 30 min in the dark. Methanosulfonic acid was added
to stop the reaction and proteins removed by centrifuga-
tion. Thiosulfate was determined by HPLC [29, 30]:
Waters-2695 module, fluorescence detector (excitation
wavelength of 380 nm, the emission wavelength of 480
nm) and a reverse-phase column. The eluants were
PIPES (10 mM, pH 6.6) and methanol (gradient). Con-
centrations were calculated by integrating the area under
the curve.
Human cartilage explants
Human cartilage (tibia and femur) from 15 OA patients
undergoing knee replacement (Kellgren-Lawrence K/L
score 1 to 4, age 64.69 years ± 10.58) was obtained from
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the Otto-von-Guericke University (Magdeburg-D). Pa-
tients were grouped into low (K/L 1–2 and OARSI 2–3,
age 70.25 ± 5.37 years), medium (K/L 3 and OARSI 3–4,
age 65.25 ± 14.88 years), and high (K/L 4 and OARSI 5,
age 59.8 ± 9.33 years) OA grade. Full-thickness cartilage
explants were fixed in 4%PFA and embedded in paraffin.
Five-micrometer-thick sagittal sections were cut for fur-
ther immunohistochemical and calcification analysis.
For HA crystal stimulation experiment, cartilage (tibia
and femur) from 4 OA patients (mean age 72 ± 10 years)
undergoing knee replacement (K/L score = 4) was ob-
tained from the Orthopedic Department (CHUV,
Lausanne-CH). Six-millimeter-diameter disks (3 disks/pa-
tient) were dissected from macroscopically intact cartilage
using a dermal punch. In order to match for location
across treatment groups, each disk was divided into two
equal parts, and each half was stimulated or not with
500 μg/ml HA crystals for 24 h in DMEM+ 1%P/S +
50 μg/ml L-ascorbic acid 2-phosphate. Cartilage was fixed
in 4%PFA for immunohistochemical analysis.
Human cartilage histology and quantification of
calcification
For each patient, three sections of full-thickness cartilage
were stained with Von Kossa/Safranin-Orange staining
(Sigma). Pictures were taken using a Zeiss Axiovert
microscope and Zen software at × 2.5 magnification, in
order to have the whole cartilage section depicted on the
picture. Images were then converted into a grayscale.
The total cartilage area (100%) was marked in the image
using ImageJ (NIH Image). The percentage (%) of calci-
fied cartilage over the total cartilage area was identified
using a threshold for black and white. The mean value
of the three sections/patient was calculated. Four to 5
patients were analyzed for each K/L-OARSI group.
Immunohistochemical analysis
3-MST expression was evaluated using an anti-3-MST
rabbit polyclonal antibody (Novusbio NBP1-82617) on
paraffin sections. The antibody was demonstrated to be
specific, as a negative staining was obtained both when
3-MST IHC was performed without the primary anti-
body (data not shown) and when 3-MST IHC was per-
formed on knee sections from 3-MST KO mice (Fig. 2a,
Sham 3-MST KO).
Analysis of 3-MST expression in sham-operated versus
meniscectomized murine knees was made by evaluation
of positivity in histological sections. In humans, for each
patient, three sections of full-thickness cartilage were
stained with the 3-MST Ab. Pictures of three fields per
section were taken using a Zeiss Axiovert microscope
and Zen software at × 10 magnification. The total num-
ber of cells and the number of 3-MST-positive cells were
counted in each field, and the percentage (%) of 3-MST-
positive cells was calculated. The mean value of the
three fields was calculated for each section and the mean
value of the three sections/patient was calculated. Four
to 5 patients were analyzed for each K/L-OARSI group.
Hydroxyapatite crystals and secondary calciprotein
particles
Hydroxyapatite crystals (HA) crystals were synthesized, char-
acterized [31], and sonicated for 5min in sterile PBS prior to
experiment. Secondary calciprotein particles (CPP) were syn-
thesized as previously described [15]. Briefly, 10% FBS, 3.5
mM phosphate (2.14mM Na2HPO4, 1.36mM NaH2PO4,
Sigma), 1mM calcium (CaCl2, Sigma), 1%P/S, and 1%L-Glu-
tamine where added to DMEM. This medium was stored at
37 °C for 7 days to generate secondary CPP and then centri-
fuged at 25000×g for 2 h at 4 °C. Calcium content was mea-
sured in the resuspended pellet by the QuantiChrom™
Calcium Kit.
Murine articular chondrocytes isolation
Primary knee immature chondrocytes were isolated from 5
to 7 days old mice [9] and amplified for 7 days in DMEM+
1%P/S + 10%FBS to reach chondrocytic differentiation [32].
For calcification studies, chondrocytes were cultivated for 24
h in DMEM+1%P/S + 10%FBS, supplemented with second-
ary calciprotein particles (CPP-50 μg/ml calcium) to induce
calcification and were concomitantly treated with 0.4%
DMSO, 500 μM H2O2 (Sigma-Aldrich, dissolved in culture
medium), 1mMN-acetylcysteine NAC (Sigma-Aldrich, dis-
solved in DMSO), or a combination of those. For qRT-PCR
studies, separate plates were used and chondrocytes were
cultivated for 4 h in DMEM+1%P/S only, supplemented
with 0.4% DMSO or 50 μM of the 3-MST inhibitor (com-
pound 3 [33], dissolved in DMSO, kindly provided by Prof.
Kenjiro Hanaoka, University of Tokyo). For alkaline phos-
phatase activity, separate plates were used and chondrocytes
were cultivated for 6 h in DMEM+1%P/S only, supple-
mented with 0.4% DMSO, 50 μM of the 3-MST inhibitor,
500 μMH2O2, or a combination of those.
Crystal detection in articular chondrocyte cultures
For Alizarin Red staining, cells were fixed in 10% formol
for 30min and calcium-containing crystals stained by ap-
plying 2% Alizarin red solution (pH 5.3) for 1 h [34]. After
washings with tap water, pictures were taken. For calcium
content quantification, separate plates were used. Cell
monolayers were decalcified with 0.6M HCl for 24 h. The
following day, calcium content was quantified by the
QuantiChrom™ Calcium Kit (BioAssay Systems) by reding
absorbance at 612 nm using the Spectramax M5e reader
(Molecular Devices).
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IL-6 quantification in articular chondrocyte cultures
Cell supernatants from the cells used for the measure-
ment of calcium content were assayed using murine IL-
6 ELISA kit (eBioscience) and by reading absorbance at
450 nm and 570 nm using the Spectramax M5e reader.
Alkaline phosphatase (Alp) activity in articular
chondrocyte cultures
Supernatant was removed, chondrocytes lysed in 0.01%
SDS (dissolved in water), and alkaline phosphatase (Alp)
activity was measured in cell lysate using a p-Nitrophenyl
Phosphate assay (Alpl Assay Kit, Abcam, ab83369) and by
reading absorbance at 405 nm.
H2S detection in articular chondrocyte cultures
Primary murine chondrocytes (106cells/condition) were
treated for 6 h with 50 μM 3-MST inhibitor or 0.4% vehicle
(DMSO). They were then resuspended in fluorescence-
activated cell sorting (FACS) buffer (5%FCS, 5mM EDTA in
PBS) and the H2S fluorescent probe P3 added (10 μM, [35]).
FACS analysis was performed right after with a UV laser
(LSRII SORP cytometer, BD Biosciences) and data processed
by FACS Diva (BD Biosciences) and FlowJoX (Tree Star).
LDH measurement in articular chondrocyte cultures
Measurement of the leakage of components from the
cytoplasm into the surrounding culture medium has been
widely accepted as a valid method to estimate the number of
non-viable cells. Lactate dehydrogenase (LDH) in the
supernatant was measured using the fluorimetric method
CytoTox-ONE™ Homogeneous Membrane Integrity Assay
(Promega), by recording fluorescence at an excitation wave-
length of 560 nm and an emission wavelength of 590 nm.
Culture medium from wells without cells was used as a nega-
tive control (0% cytotoxicity), while medium from wells with
lysed cells (1% Triton X-100) was used as a positive control
(100% cytotoxicity). The percent cytotoxicity of each experi-
mental wells was then calculated as follows: Percent cytotox-
icity = [(Experimental value)-(Culture medium value)]/
[(Positive control value)-(Culture medium value)]× 100.
ATDC5 chondrogenic cell line
For qRT-PCR analysis, ATDC5 cells (from ATCC cell
line) were cultured in DMEM/F12 (1%P/S only) and
treated for 4 h with different combinations of 0.4%
DMSO (Sigma-Aldrich), 50 μl/ml CPP, 50 μM 3-MST
inhibitor, and 500 μM H2O2. For reactive oxygen species
(ROS) measurement, separate plates were used and
ATDC5 were cultured in DMEM/F12 without phenol
red and FBS and cells were treated with the same condi-
tions described above, or with 10 ng/ml mouse recom-
binant IL-6 (Gibco, dissolved in DMSO) where
indicated.
ROS level measurement in ATDC5 cells
Mitochondrial ROS level was measured with Red Mito-
chondrial Superoxide Indicator (MitoSOX, Life Tech-
nologies). Briefly, ATDC5 in half area 96-wells clear
bottom black plate were stimulated or not for 1 h with
50 μl/ml CPP and treated or not with vehicle 0.4%
DMSO, 50 μM 3-MST inhibitor, 50 μM H2O2, 1 mM
NAC, or 10 ng/ml IL-6 in DMEM/F12 without phenol
red. After stimulation, cells were loaded 30min with
5 μM MitoSOX, and fluorescence intensity measured
(excitation wavelength of 510 nm, emission wavelength
of 580 nm) using the Spectrax M5e reader.
Wells with cells-DMEM/F12 only, as well as wells with
MitoSOX-DMEM/F12 only, were also included in order
to measure cells and MitoSOX autofluorescence, re-
spectively. These background values were then sub-
tracted to the experimental wells values, and the
obtained results were plotted as MitoSOX signal (A.U).
Real-time PCR analysis in articular chondrocyte cultures
and ATDC5 cells
Cells were lysed in TRIzol reagent (Thermo Scientific) in a
ratio of 500 μl TRIzol every 106 cells. RNA was extracted
(RNA Clean and Concentrator5, Zymoresearch), reverse
transcribed (Superscript II, Invitrogen), and quantitative Real
Time-PCR (qRT-PCR) with gene-specific primers (Table 1)
using the LightCycler480®system (Roche Applied Science)
was performed. Each reaction mix was composed by 3.75 μl
LightCycler 480 SYBR Green I Master (Roche) + 0.75 μl of
5 μM primer pair specific for each gene+ 0.5 μl of LightCy-
cler Water (Roche) + 2.5 μl of 20 ng/μl cDNA. Wells with
RNase/DNase-free water instead of cDNA were included for
each amplified gene as a negative control.
Table 1 Murine gene specific primers for qRT-PCR
Gene Forward primer (5′ ➔ 3′) Reverse primer (5′➔ 3′)
mAnk TGT CAA CCT CTT CGT GTC CC GAC AAA ACA GAG CGT
CAG CG
mAlpl TTG TGC CAG AGA AAG AGA GAG GTT TCA GGG CAT TTT
TCA AGG T
mAnx5 CCT CAC GAC TCT ACG ATG CC AGC CTG GAA CAA TGC
CTG AG
mPit-1 CTC TCC GCT GCT TTC TGG TA AGA GGT TGA TTC CGA
TTG TGC
mPit-2 AAA CGC TAA TGG CTG GGG AA AAC CAG GAG GCG ACA
ATC TT
m3-Mst CTG GGA AAC GGG GAG CG GCT CGG AAA AGT TGC
GGG
mTbp CTT GAA ATC ATC CCT GCG AG CGC TTT CAT TAA ATT
CTT GAT GGT C
mGapdh CTC ATG ACC ACA GTC CAT GC CAC ATT GGG GGT AGG
AAC AC
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Data was normalized against Tbp and Gapdh refer-
ences genes, with fold induction of transcripts calculated
against control cells.
Statistical analysis
For human ex vivo experiments, values represent
means ± SD and 4 to 5 patients per group were analyzed.
For in vitro experiments, values represent means ± SD of
triplicates. For each readout, three independent experi-
ments were performed. For in vivo experiments, eight
mice per group were used.
Data was analyzed with GraphPad Prism software. The
variation between data sets was evaluated using Stu-
dent’s t test or one-way or two-way ANOVA test, where
appropriate. Bonferroni correction was used as a post
hoc analysis in case of multiple comparisons. Correlation
between parameters was evaluated using the correlation
test and expressed by the Pearson correlation coefficient
(− 1 < r < 1). Differences were considered statistically sig-
nificant at *p < 0.05, **p < 0.01, ***p < 0.001, and ****p <
0.0001.
Results
3-MST expression in human cartilage negatively
correlates with OA severity and chondrocyte calcification,
and it is downregulated by HA crystals
Immunohistochemistry on human OA cartilage (Fig. 1a)
revealed high 3-MST expression by chondrocytes in the
superficial area of cartilage and low expression in
intermediate-deep layers. In contrast, chondrocyte calci-
fication was present in deep cartilage and negative in the
superficial zone. Thus, we found a trend (p = 0.08) to-
wards an inverse correlation (r = − 0.48) between the two
parameters (graph Fig. 1a). When specimens were di-
vided into low, medium, or high OA, 3-MST expression
was decreased by 20–30% in medium and high OA
(Fig. 1b), while chondrocyte calcification was increased
as assessed by von Kossa staining (Fig. 1b). We next
stimulated cartilage explants with HA crystals for 24 h
(Fig. 1c). 3-MST expression was significantly inhibited
by HA crystals in four patients, although at different de-
grees (Fig. 1c). Altogether, these results indicate that
chondrocyte calcification increases during OA progres-
sion and negatively impacts on 3-MST expression pro-
portionally to disease severity.
3-MST regulates joint calcification and cartilage damage
in experimental OA
To investigate the role of 3-MST in the pathogenesis of
osteoarthritis, we subjected 3-MST deficient mice (3-
MST KO) to meniscectomy. As in human OA samples,
we observed that 3-MST expression was higher in sham-
operated healthy knees than in osteoarthritic MNX
knees (Fig. 2a). Twomonths post-surgery, CT-scans
evidenced increased calcification in 3-MST KO knees if
compared to WT knees (Fig. 2b, white arrows). Quanti-
tative analysis of calcifications revealed that both their
volume and their overall crystal content were signifi-
cantly higher in 3-MST KO mice (graphs Fig. 2b). In
parallel, cartilage damage (fissures and fibrillations, black
arrows) as well as proteoglycan loss (reduced Safranin-O
staining) were exacerbated in 3-MST KO joints com-
pared to WT joints, as mirrored by both histological
analysis and OARSI scores (Fig. 2c). Finally, serum thio-
sulfate level was higher in WT mice than in 3-MST KO
mice (Fig. 2d).
3-MST regulates chondrocyte mineralization and IL-6
secretion in vitro
After 24 h in the presence of CPP, 3-MST KO chondro-
cytes had exacerbated mineralization as demonstrated by
Alizarin red staining (Fig. 3a) and by quantification of
calcium content in the cell monolayer (graph Fig. 3a). In
parallel, we found that 3-MST KO cells secreted higher
levels of basal IL-6 than WT cells (Fig. 3b). This would
support our previous finding that IL-6 sustains
mineralization in chondrocytes [9]. As the second
approach to lower 3-MST activity, we treated WT chon-
drocytes with a pharmacological 3-MST inhibitor.
Firstly, we confirmed by FACS that the 3-MST inhibitor
significantly decreased H2S production by chondrocytes
(Fig. 3c). In accordance with the findings in 3-MST KO
chondrocytes (Fig. 3a), treatment with the 3-MST inhibi-
tor triggered chondrocyte mineralization (Fig. 3d). Con-
versely, stimulation of chondrocytes with crystals (HA or
CPP) caused 3-MST downregulation (Fig. 3e). Accord-
ingly, the addition of IL-6 also decreased 3-MST expres-
sion by 2-fold (Fig. 3f). Altogether these results suggest
that two of the main OA triggers (calcium-containing
crystals and IL-6) negatively affect the endogenous gen-
eration of H2S by 3-MST and vice-versa.
Oxidative stress regulates 3-MST expression and
mineralization in chondrocytes
Oxidative stress has been implicated in the progression
of OA via different mechanisms [36], but never via a dir-
ect role in chondrocyte calcification. We found that
H2O2 stimulation led to significantly decreased 3-MST
expression (Fig. 4a) in chondrocyte, but concomitantly
increased calcification (Fig. 4b), while the ROS scavenger
NAC reverted the latter effect. Cell viability was not af-
fected in any conditions (Fig. 4c). Inversely, neither pro-
moters of calcification (CPP and IL-6) nor H2S
inhibition (3-MST inhibitor) altered mitochondrial ROS
production by chondrocytes (Fig. 4d). Taken together,
these results support a deleterious role of ROS upstream
to chondrocyte calcification and inflammation, likely
mediated by inhibition of 3-MST-generated H2S.
Nasi et al. Arthritis Research & Therapy           (2020) 22:49 Page 5 of 12
Finally, we assessed the expression of genes involved
in the calcification process in chondrocyte cultured in
presence of CPP, or H2O2, or 3-MST inhibitor. H2O2
significantly increased Ank and Anx5 expression, as the
pro-calcifying stimulus CPP and the 3-MST inhibitor
did (Fig. 4e). This strengthens the hypothesis that H2O2
may induce chondrocyte calcification via inhibition of
endogenous H2S production. Alpl expression (Fig. 4e)
and activity (Fig. 4f), and Pit1 and Pit2 expression were
not modulated in all conditions.
Discussion
A large body of evidence supports the idea that calcium-
containing crystals are active players in the initiation
and progression of OA [5, 9, 37, 38]. However, the
mechanisms of cartilage calcification are largely un-
known and to date, there is no treatment that can pre-
vent crystal deposition or dissolve already formed
calcifications.
Here, we have demonstrated that the 3-MST/H2S
pathway is involved in cartilage calcification and OA
Fig. 1 Cartilage 3-MST expression is negatively correlated with OA severity and chondrocyte calcification and downmodulated by HA crystals.
a 3-MST immunohistochemical staining in cartilage explants from end-stage osteoarthritis patients and consecutive sections stained with von
Kossa/Safranin-O staining for calcium-containing crystals. For each staining, one representative picture from one out of 14 patients is shown. Scale
bars 200 μm. The graph shows the correlation between the % of 3-MST-positive cells and the % of calcified cartilage in the different patients.
n = 14 patients. b Immunohistochemical staining of 3-MST in cartilage from individuals with low, medium, and high stage osteoarthritis and von
Kossa/Safranin-O staining for calcium-containing crystals in consecutive sections. Pictures from one representative patient out of 5 patients per
group are shown. Scale bars 200 μm. The graphs show the % of 3-MST-positive cells and the % of calcified cartilage. Three fields were counted
per patient and the mean plotted in the graph. n = 14 patients. c 3-MST immunohistochemistry of human cartilage explants stimulated 24 h with
HA crystals (HA 500 μg/ml) or not (Nt). Scale bars 200 μm. The graph shows the % of 3-MST-positive cells in Nt vs HA-treated explants in each
patient. Lines connect the Nt condition and the HA condition for each patient. n = 4 patients
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progression. Decreasing the endogenous level of H2S in
chondrocytes, either genetically by 3-MST deficiency or
pharmacologically by an 3-MST inhibitor, led to exacer-
bated mineralization in vitro (Fig. 3a, d). A proof of con-
cept of the protective role of 3-MST-generated H2S was
given by the in vivo MNX model, where 3-MST-
deficient mice were affected by joint calcification and
cartilage degradation (Fig. 2b, c) more severely than WT
mice. Another evidence was that in knee cartilage from
both MNX mice (Fig. 2a) and OA patients (Fig. 1b) we
found an inverse correlation between 3-MST expression,
and the extent of calcification as well as OA severity.
3-MST deficiency in humans is responsible for a rare
inheritable disorder called mercaptolactate-cysteine
disulfiduria (MCDU) [39]. MCDU patients are not only
mainly affected by mental retardation [25], but can also
exhibit skeletal abnormalities (high forehead, arachno-
dactyly, genum valgum, and joint hyperflexibility
(Orphanet:1035)). Other studies support a protective
role of H2S in pathological mineralization. H2S de-
creased vascular calcification [15, 17, 18, 40], while in-
hibition of CSE activity caused the opposite effect [18].
The H2S-donor sodium thiosulfate (STS) inhibited knee
joint calcification during experimental OA [37]. On the
other hand, some studies demonstrated the pro-
mineralizing effect of H2S. H2S induced physiological
mineralization of human periodontal [41] and mesen-
chymal [42] stem cells. CBS deficiency was associated
Fig. 2 3-MST deficiency exacerbates joint calcification and cartilage damage in experimental OA. a Representative immunohistochemical analysis
of 3-MST expression in the knee section from sham-operated and MNX WT mice. A knee section from a sham-operated 3-Mst KO mouse was
used to prove the specificity of the 3-MST antibody. Scale bars 150 μm. b Representative micro-CT scan images of WT and 3-MST KO MNX murine
knee joints two months after surgery. White arrows show calcified periarticular deposits in MNX WT knees and their exacerbation in 3-MST KO
mice. Graphs show CTAnalyzer quantitative analysis of new formation volume (mm3) and new formation crystal content (μg) in WT and 3-MST
KO MNX knees. c Representative histologies of WT and 3-MST KO MNX knees, stained with Safranin-O. Black arrows show increased cartilage
degradation in 3-MST KO mice. Scale bars 150 μm. Graphs show femoral scoring of cartilage damage and Safranin-O loss, accordingly to OARSI
method. d Thiosulfate measurement in the serum of WT and 3-MST KO mice. Mice number WT n = 8, 3-MST KO n = 8
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with human [43] and murine [44] osteoporosis. Further-
more, the H2S-donor GYY4137 stimulated bone forma-
tion in vivo [45, 46].
While all these studies investigated the CBS/H2S or
the CSE/H2S pathway in mineralization, to our know-
ledge, we are the first to highlight the importance of the
3-MST/H2S pathway in this context. We will discuss
here below the mechanisms by which lack of 3-MST-
generated H2S could facilitate chondrocyte calcification
and OA progression and the time-course of the events.
The very first mechanism involved seems to be reduced
3-MST expression/activity by increased oxidative stress.
We indeed showed here that hydrogen peroxide (H2O2), a
major reactive oxygen species (ROS), was able to decrease
3-Mst expression (Fig. 4a). The effect of ORS on 3-MST
can also occur at the post-transcriptional level, as it was
shown previously that H2O2 inhibited the activity of
mouse recombinant 3-MST and further H2S generation
[47]. Subsequently to 3-MST inhibition, we showed that
H2O2 exacerbated chondrocyte mineralization (Fig. 4b)
while the ROS scavenger NAC reverted this effect. Other
studies exist in the literature that supports an important
role or ROS in triggering chondrocyte calcification [48]
and metalloproteases production [49, 50], ultimately lead-
ing to OA progression. The fact that preventing oxidative
stress is beneficial in reducing chondrocyte calcification,
was also highlighted in a previous study from our group,
in which we demonstrated that the H2S metabolite
Fig. 3 Endogenously H2S produced by 3-MST regulates chondrocytes calcification and IL-6 secretion and vice versa. a Alizarin red staining of WT
and 3-MST KO chondrocytes cultured with CPP for 24 h. Pictures represent triplicates from one experiment of three independent experiments.
Graph represents calcium content in the cell monolayer, expressed in μg Ca/μg protein. n = 3. b IL-6 secretion in cell supernatant of WT and 3-
MST KO chondrocytes from point (a). n = 3. c FACS analysis of endogenous H2S production by WT chondrocytes treated for 6 h with vehicle
(DMSO) or 50 μM 3-MST inhibitor and incubated with P3 probe. n = 3. d Alizarin red staining of WT chondrocytes cultured in CPP for 24 h in the
presence or absence of 50 μM 3-MST inhibitor. Pictures represent triplicates from one experiment of three independent experiments. Graph
represents calcium content in the cell monolayer, expressed in μg Ca/μg protein. n = 3. e qRT-PCR for 3-Mst gene expression in WT chondrocytes
stimulated or not with 500 μg/ml HA crystals or CPP for 4 h, or with (f) 10 ng/ml IL-6. n = 3
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thiosulfate was able to decrease ROS production and calci-
fication in chondrocytes [37]. We therefore hypothesize
that increased oxidative stress inhibits 3-MST/H2S ultim-
ately leading to increased chondrocyte calcification. Im-
portantly, while ROS suppressed 3-MST/H2S pathway
and induced calcification, we could not found the oppos-
ite, that is 3-MST inhibition or calcification trigger (CPP)
did not increase mitochondrial ROS production. This
could be because the 3-MST function in mitochondria is
compensated by another enzyme called rhodanese [51].
Further investigations are needed to determine if de-
creased 3-MST/H2S impact on total ROS production in
chondrocytes.
We next investigated in more details the possible under-
lying mechanisms by which 3-MST inhibition could ex-
acerbate calcification in chondrocytes, and found that
both 3-MST inhibitors (H2O2 and the 3-MST inhibitor it-
self) caused upregulation of calcification genes such as
Ank and Anx5 (Fig. 4e). This is in line with our previous
data of Anx5 downregulation by the H2S metabolite thio-
sulfate [37]. The expression or the activity of other calcifi-
cation enzymes and channels (Alpl, Pit1, Pit2) were not
impacted by H2O2 or the 3-MST inhibitor (Fig. 4e, f).
An additional trigger of chondrocyte calcification is
known to be inflammation. In particular, in our study
from 2015 [9], we demonstrated that a vicious cycle ex-
ists between chondrocyte calcification and the pro-
inflammatory cytokine IL-6. In the current study, we
demonstrated that 3-MST inhibition (3-MST deficient
chondrocytes), led not only to increased calcification but
also to increased IL-6 secretion by chondrocytes (Fig. 3b).
Conversely, we found that both pro-calcifying factors
(HA, CPP) and pro-inflammatory factors (IL-6) led to
the downregulation of 3-Mst expression (Fig. 3e, f), thus
reducing H2S. This loop is shown in Fig. 5.
A thing that remains to be clarified is whether the
effects caused by inhibition of the 3-MST (exacerbated
calcification and inflammation) are due to decreased
levels of H2S or one of its metabolites such as thiosul-
fate. In 3-MST KO mice, which have decreased serum
levels of H2S [25], we also found decreased serum levels
of thiosulfate (Fig. 2b). We previously demonstrated that
thiosulfate is protective against joint calcification and
cartilage degradation in experimental OA, likely due to
its anti-inflammatory, antioxidant, and anti-catabolic
properties [37].
Fig. 4 Oxidative stress regulates 3-MST expression, mineralization, and inflammation in chondrocytes. a qRT-PCR for 3-Mst gene expression in WT
chondrocytes stimulated or not with 500 μM H2O2 for 4 h. n = 3. b Calcium content in chondrocytes monolayer incubated for 24 h with CPP and
treated with vehicle (DMSO) or 500 μM H2O2 or with 1 mM NAC or with a combination of them. Calcium content is expressed in μg Calcium/μg
protein. c LDH release in cell supernatant of chondrocytes from point (b). n = 3. d Mitochondrial ROS production (MitoSOX) in chondrocytes
treated with vehicle (DMSO), or 50 μM 3-MST inhibitor or CPP or 10 ng/ml IL-6 for 1 h. n = 3. e qRT-PCR of the indicated genes in chondrocytes
stimulated with vehicle (DMSO), or 500 μM H2O2, or 50 μM 3-MST inhibitor or CPP for 4 h. n = 3. f Alp activity in chondrocytes lysates treated with
vehicle, or 500 μM H2O2, or 50 μM 3-MST inhibitor for 6 h. n = 3
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Finally, further data are needed to determine whether
the other H2S producing enzymes have a role in calcifi-
cation in OA. Although we have already excluded a
major role for CBS (because not expressed in cartilage,
and because we did not observe any OA phenotype in
CBS KO mice, data not shown), it is likely that CSE,
which is expressed by chondrocytes [52], may as well
have a role in joint calcification.
Conclusions
We have established a key role for the 3-MST/H2S axis in
the regulation of pathological chondrocyte calcification in
OA. Oxidative stress is an upstream event leading to reduced
3-MST/H2S levels. Impaired 3-MST/H2S levels increase
chondrocyte calcification and IL-6 secretion. Moreover,
calcium-containing crystals and IL-6 can in turn inhibit 3-
MST-mediated H2S production, resulting in even greater
mineralization and OA progression (Fig. 5). Whether these
phenotypes are due to the lack of H2S, or the lack of one of
its metabolites such as thiosulfate, or the accumulation of the
3-MST substrate 3-mercaptopyruvate remains to be investi-
gated. Our results suggest that augmenting H2S production
by 3-MST activation may be an approach to treat calcifying
disorders.
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